Skip to content

Family and Social Services Administration

< Back | Agency Home | Submit Events >

Search events. View events.
Display Format:  Family and Social Services Administration Submit Events
Welcome to the IN.gov Calendar. Please use the Help button to the right for any assistance while using the Calendar.
 Click for help in using calendar displays. Print the contents of the current screen.
Display Month:
Advanced Search (New Search)
From:  From:
To:  To:
State Agency(s):
Entry Type: 

Entry Category: 

IN.gov Category: 

Keyword(s):
Submit
Entry Details
Notify me if this event changes.Add this event to my personal calendar.Email this entry to a friend.
Go Back
[FSSA] Therapeutics Committee Meeting
Start Date: 2/1/2013Start Time: 9:00 AM
End Date: 2/1/2013
This event recurs every 3 months on the first Friday until 2/1/2013.  Click here to see the series dates.
Entry Description

Therapeutics Committee Meeting
Indiana Government Center South
Conference Center Room A

1. Call to Order-Chair
2. Opening Comments-OMPP
3. Approval of Memoranda, Meetings of November 2, 2012
4. Preferred Drug List: Therapeutic Class Re-Review

a. Respiratory

i. Antihistamine-Decongestant Combinations, 2nd Generation Antihistamines
ii. Antiviral Monoclonal Antibodies
iii. Beta Adrenergics and Corticosteroids
iv. Beta Agonists
v. Bronchodilator Agents, Beta Adrenergic & Anticholinergic Combinations
vi. Leukotriene Receptor Antagonists
vii. Monoclonal Antibodies to Immunoglobulin E
viii. Nasal Antihistamines, Nasal Anti-inflammatory Steroids
ix. Oral Inhaled Glucocorticoids
x. Phosphodiesterase-4 Inhibitors
xi. Pulmonary Antihypertensives – Phosphodiesterase Type 5 Inhibitors

b. Anti-infectives

i. Antivirals – Anti-herpetic
ii. Antivirals – Anti-influenza
iii. First- and Third-Generation Cephalosporins
iv. Fluoroquinolones
v. Hepatitis C Agents
vi. Ketolides
vii. Macrolides
viii. Ophthalmic Antibiotics
ix. Oral Non-Systemic Antifungals
x. Otic Antibiotics
xi. Systemic Antifungals
xii. Topical Antifungals
xiii. Topical Antivirals
xiv. Topical Antiviral and Antiinflammatory Steroid Combinations
xv. Vaginal Antimicrobials

c. Cardiovascular

i. ACE Inhibitors
ii. ACE Inhibitors in combination with CCBs
iii. ACE Inhibitors in combination with Diuretics
iv. ARBs
v. ARBs in combination with CCBs
vi. ARBs in combination with CCBs and Diuretics
vii. ARBs in combination with Diuretics
viii. Alpha-Beta Adrenergic Blockers
ix. Beta Adrenergic Blockers
x. Beta Blockers with Diuretics
xi. Calcium Channel Blockers
xii. Calcium Channel Blocker with HMG CoA Reductase Inhibitors(Caduet)
xiii. Direct Renin Inhibitors
xiv. Direct Renin Inhibitors in combination with ARBs
xv. Direct Renin Inhibitors in combination with CCBs
xvi. Direct Renin Inhibitors in combination with CCBs and Diuretics
xvii. Direct Renin Inhibitors in combination with Diuretics
xviii. Potassium Sparing Diuretics (Inspra)

d. Lipotropics

i. Bile Acid Sequestrants
ii. Fibric Acid Derivatives
iii. HMG CoA Reductase Inhibitors
iv. Lipotropics
e. Antimigraine Preparations
f. DPP4-HMG CoA Reductase Inhibitor Combinations
g. Electrolyte Depleters
h. MS Agents

5. Proposed New Therapeutic Classes for May 2013 Review

i. Beta-3 Adrenergic Agonists (Myrbetriq)
ii. Janus Kinase Inhibitors (Xeljanz)

6. Discussion on Diastat
7. Public Comment
8. Other Business
9. Adjourn
Default
Entry Type:
Event
Entry Category:
  • Hearings
  • Meetings
    		•
    IN.gov Category:
  • Family & Health
    		•
    Agency Name
    Family and Social Services Administration

    Calendar software powered by Active Data Calendar   
    Select item(s) to Search








    Select item(s) to Search
    Select item(s) to Search

    Select item(s) to Search